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Production of interleukin-17 (IL-17) and IL-22 by T
helper 17 (Th17) cells and group 3 innate lymphoid
cells (ILC3s) in response to the gut microbiota en-
sures maintenance of intestinal barrier function.
Here, we examined themechanisms whereby the im-
mune system detects microbiota in the steady state.
A Syk-kinase-coupled signaling pathway in dendritic
cells (DCs) was critical for commensal-dependent
production of IL-17 and IL-22 by CD4+ T cells.
The Syk-coupled C-type lectin receptor Mincle de-
tected mucosal-resident commensals in the Peyer’s
patches (PPs), triggered IL-6 and IL-23p19 expres-
sion, and thereby regulated function of intestinal
Th17- and IL-17-secreting ILCs. Mice deficient in
Mincle or with selective depletion of Syk in CD11c+
cells had impaired production of intestinal RegIIIg
and IgA and increased systemic translocation of
gut microbiota. Consequently, Mincle deficiency led446 Immunity 50, 446–461, February 19, 2019 ª 2018 The Author(s).
This is an open access article under the CC BY-NC-ND license (http://to liver inflammation and deregulated lipid meta-
bolism. Thus, sensing of commensals by Mincle
and Syk signaling in CD11c+ cells reinforces intesti-
nal immune barrier and promotes host-microbiota
mutualism, preventing systemic inflammation.
INTRODUCTION
The intestinal microbiota contributes to host metabolism, resis-
tance to pathogen colonization, and host immune system devel-
opment and homeostasis (B€aumler and Sperandio, 2016; Honda
and Littman, 2016). However, its containment is essential, and
increased microbial translocation is associated with systemic
inflammation (Sonnenberg et al., 2012). The intestinal epithelial
cells (IECs), themucus layer, the generation of antimicrobial pep-
tides, and the synthesis of microbe-specific immunoglobulin A
(IgA) in the Peyer’s patches (PPs) constitute the ‘‘mucosal fire-
wall’’ (Belkaid and Hand, 2014). This barrier is regulated by
RORgt-dependent cells that include group 3 innate lymphoid
cells (ILC3s) and T helper 17 (Th17) cells, which produce IL-17Published by Elsevier Inc.
creativecommons.org/licenses/by-nc-nd/4.0/).
and IL-22 and modulate antimicrobial peptide secretion by IECs
and IgA production in the gut (Hirota et al., 2013; Kruglov et al.,
2013). Therefore, the absence of RORgt-dependent cells or their
mediators can lead to a breach of the intestinal barrier,
commensal translocation, and systemic inflammation (Lochner
et al., 2011; Sonnenberg et al., 2012).
The intestinal microbiota critically contributes to the genera-
tion and function of RORgt-dependent cells (Ivanov et al.,
2008; Sanos et al., 2009; Satoh-Takayama et al., 2008). For
instance, segmented filamentous bacteria (SFB) induce the
release of serum amyloid A (SAA) proteins that promote local
IL-17 production, myeloid-mediated IL-22 secretion by ILC3,
and IgA responses (Atarashi et al., 2015; Gaboriau-Routhiau
et al., 2009; Ivanov et al., 2009; Sano et al., 2015). Myeloid cells
are critical to integrating the intestinal microenvironment and
adaptive immune responses. Macrophages or dendritic cells
(DCs) can be located in the lamina propria (LP) and/or in gut-
associated lymphoid tissues, including PPs (Bekiaris et al.,
2014). On the basis of the expression of lysozyme and CD11b,
PPs contain particular subsets of DCs (Bonnardel et al., 2015;
Da Silva et al., 2017). Th17 cell differentiation requires antigen
recognition in the context of major histocompatibility complex
II (MHCII), as well as IL-6 and transforming growth factor-b
(TGF-b) from DCs (Ivanov et al., 2006; Persson et al., 2013). In
contrast, activation of ILC3s is antigen independent but, in
turn, requires the production of IL-23 by myeloid cells to release
IL-22 and/or IL-17 (Longman et al., 2014; Satpathy et al., 2013).
However, the particular subset of myeloid cells and the host
signaling pathways linking recognition of commensal microbes
to the induction of IL-17 and IL-22 production by RORgt+ cells
in the steady state are poorly understood.
Some Syk-kinase-coupled C-type lectin receptors (CLRs),
such as Dectin-1 (Clec7a), Dectin-2 (Clec4n), and Mincle
(Clec4e), preferentially induce myeloid IL-6, IL-1b, and IL-23
secretion upon recognition of different components of the fungal
or bacterial pathogen cell wall, promoting Th17polarization (Geij-
tenbeek and Gringhuis, 2016; LeibundGut-Landmann et al.,
2007). Therefore, we investigated whether Syk-coupled CLRs
could contribute to myeloid cell sensing of the intestinal micro-
biota to promote functional responses in RORgt+ cells under
homeostatic conditions.We found that sensing ofmucosa-asso-
ciated commensals by the Mincle and Syk pathway in lysozyme-
expressing DCs (LysoDCs) and CD11b+ dome DCs from PPs
contributes to IL-6 and IL-23p19 production by these cells. These
myeloid-cell-derived cytokines regulate IL-17 and IL-22 produc-
tion by T cells and ILCs, promoting intestinal barrier function and
limiting microbial translocation, which is associated with inflam-
mation and deregulated metabolism in the liver.
RESULTS
Mincle and Syk Signaling in DCs Controls Microbiota-
Driven Th17 Differentiation
We assessed host signaling pathways with the potential to link
recognition of commensal microbes by myeloid cells with Th17
differentiation. CD11c+ cells derived from bone marrow cultured
with GM-CSF (GM-BMs) from mice lacking MyD88 (Myd88/)
(Adachi et al., 1998) or Syk in the CD11c+ compartment
(CD11cCre Sykflox/flox, named CD11cDSyk mice) (Iborra et al.,2012; Whitney et al., 2014) or GM-BMs fromwild-type (WT) litter-
mates were loaded with chicken ovalbumin class-II peptide
(OVA323–339) and co-cultured with naive OVA-specific (OT-II)
CD4+ T cells in the presence or absence of specific-pathogen-
free (SPF) gut microbiota. Although the proliferation of OT-II cells
did not differ upon co-culture with different GM-BMs (Fig-
ure S1A), OT-II cell capacity to produce IL-17 after priming in
the presence of gut microbiota was specifically blunted in the
absence of Syk, but not MyD88, in GM-BMs (Figure 1A).
Syk signaling following pattern recognition is characteristic of
some CLRs. Syk binds to immunoreceptor tyrosine-based acti-
vation motif (ITAM) domains present in the FcRg chain (Fcer1g)
adaptor that couples to Dectin-2 (Clec4n) or Mincle (Clec4e) or
to hemITAMs borne by CLRs, such as Dectin-1 (Clec7a) (Iborra
and Sancho, 2015). Thus, we explored the ability of GM-BMs
lacking Dectin-1 or the FcRg chain to promote microbiota-driven
Th17 differentiation from naive OT-II cells as above. Although
OT-II cell proliferation following stimulation with GM-BMs was
similar among the different GM-BM genotypes tested (Fig-
ure S1B), microbiota-induced Th17 differentiation was depen-
dent on the expression of the FcRg chain, but not Dectin-1, in
GM-BMs (Figure 1B). We subsequently found that, upstream
of the FcRg chain, Mincle, but not Dectin-2, was needed in
GM-BMs for microbiota-driven Th17 differentiation in vitro (Fig-
ures 1C and S1C). Notably, exposure to microbiota induced
Syk phosphorylation in GM-BMs in a Mincle-dependent manner
(Figure S1D).
GM-BMs comprise conventional DCs (GM-DCs) and mono-
cyte-derived macrophages (GM-Macs) (Helft et al., 2015). GM-
Macs expressed Mincle constitutively, whereas intestinal
microbiota stimulation induced Mincle expression in GM-DCs
(Figure S1E), as expected (Helft et al., 2015). In addition, we
found that GM-DCs efficiently primed IL-17 and IL-22 production
by OT-II cells in response to microbiota and in a Mincle-depen-
dent fashion (Figures 1D–1F). In contrast, GM-Macs promoted
IFN-g-producing OT-II cells in a Mincle-independent manner
(Figure 1G). These results suggest that the Mincle-FcRg-chain-
Syk axis in GM-DCs drives Th17 differentiation in response to in-
testinal commensals.
Mincle Senses Mucosa-Associated Commensals
We tested whether the intestinal microbiota contains a functional
ligand for Mincle by analyzing the capacity of commensals to
activate GM-BMs. Upregulation of MHCII, CCR7, and CD86
in GM-BMs by microbiota was significantly reduced in the
absence of Mincle (Figure S2A). As expected in controls for the
experiment, activation of GM-BMs by the Mincle ligand treha-
lose-6,6-dibehenate (TDB) was Mincle dependent, whereas
activation mediated by lipopolysaccharide (LPS) was Mincle in-
dependent (Figure S2A). These results suggest that Mincle
senses microbiota and thereby contributes to DC activation.
We next investigated whether Mincle could bind to the
intestinal microbiota from our SPFmice. Mincle-ectodomain-hu-
man-Fc chimera (Mincle-hFc) recognized the microbiota in a
dose-dependent manner (Figures 2A and S2B). Pre-incubation
of Mincle-hFc with 2F2 anti-Mincle antibody or with the Mincle
ligand TDB specifically prevented its binding to the microbiota
(Figure S2C). In addition, Mincle-hFc did not bind to the gastro-
intestinal content from germ-free mice (Figure S2C). Notably, theImmunity 50, 446–461, February 19, 2019 447
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Figure 1. Mincle and Syk Signaling in DCs Control Microbiota-Driven Th17 Differentiation
(A–C) Naive OT-II T cells were co-cultured with GM-BMs (1:2 ratio) from: (A) WT mice or mice lacking MyD88 (Myd88/) or Syk in the CD11c+ compartment
(CD11cDSyk); (B) WT mice or mice lacking Clec7a or mice lacking Fcer1g; (C) WT mice or mice lacking Clec4n or Clec4e, the indicated genotypes loaded with
OVA peptide in the presence or absence of microbiota (10:1 GM-BM ratio), and IL-17 was measured by ELISA in the supernatant 3 days later.
(D–G) Naive OT-II T cells were co-cultured with GM-Macs or GM-DCs (1:1 ratio) loaded with OVA peptide in the presence or absence of microbiota
(10:1 DC ratio) , and IL-17 was measured by ELISA in the supernatant 3 days later (D). IL-17 (E), IL-22 (F), and IFN-g (G) production after re-stimulation was
measured by intracellular staining and flow cytometry in OT-II T cells from the co-cultures. To the left is a representative plot, and to the right quantification
is shown.
Individual data represent data generated from independent GM-BM cultures (biological replicates) in pools of at least two independent experiments. Individual
data and arithmetic mean are shown. ***p < 0.001 (one-way ANOVA and Bonferroni post hoc test). See also Figure S1.analysis of small intestine mucosa from SPF mice revealed a
more than 3-fold average enrichment in Mincle-hFc-labeled
commensals compared with the luminal fraction (Figures 2B,
2C, and S2D). We additionally found that a fraction of luminal
but not mucosa-associated microbiota was detected by hFc448 Immunity 50, 446–461, February 19, 2019chimeras of the Syk-coupled CLRs Dectin-1 and Dectin-2
(Figure S2E).
Comparative 16S sequencing analysis of Mincle-hFc-bound
and -depleted microbial fractions, along with a control-hFc-
bound fraction, revealed that Lactobacillus was one of the
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main genera enriched inMincle-hFc-bound fractions (Figure 2D).
Mincle-hFc-stained Lactobacillus was recovered from the small
intestine epithelium of mice orally gavaged with Celltrace-Violet-
labeled L. plantarum but, intriguingly, not the same bacteria
growing in MRS Broth (Figures 2E and S2F). These results indi-
cate that some phyla of mucosa-associated commensals,
including Lactobacillus, might contain ligands for Mincle (Shah
et al., 2016).
Mincle Is Expressed in DCs from PPs
Lactobacillus exhibits a preferential binding to the follicle-associ-
ated epithelium of the PPs (Plant and Conway, 2001). We
hypothesized that Mincle-expressing cells that sense mucosa-
resident commensals could be located in the gut-associated
lymphoid tissue. Indeed, Mincle was expressed in PPs (Fig-
ure 2F), and FcRg-chain-dependent Mincle expression was
restricted to the CD11c+MHCII+CD19CD11b+ subset in PPs
(Figure 2G). Confocal microscopy of PP whole-mount prepara-
tions confirmed the selective Mincle expression in the CD11c+
CD11b+ immune compartment (Figure S2G). Concurring with
previously published results (Bonnardel et al., 2015), Mincle
was mainly expressed by some lysozyme-expressing macro-
phages (LysoMacs), lysosyme-expressing DCs (LysoDCs), and
dome CD11b+ DCs, but not dome CD8a+ DCs (Figures 2H and
S2H). In contrast, Mincle expression in small intestine LP was
mainly found on macrophages but not in CD64 DC subsets
(Figures 2I and S2I). Mincle expression in human intestinal sam-
ples from healthy donors was revealed in a fraction of CD45+
CD64CD14CD11c+HLA-DR+ cells by flow cytometry and
immunohistochemistry (IHC) (Figures 2J and S2J). These results
indicate that Mincle is expressed by macrophages in PPs and
small intestine LP and by some DCs in the mouse PPs.
DCs from PPs Instruct Mincle- and Syk-Dependent Th17
Differentiation
Next, we explored the contribution of freshly isolated dome
CD11b+ DCs, dome CD8a+ DCs, LysoMacs, and LysoDCsFigure 2. Mucosa-Associated Commensals Are Sensed by PP DCs Ex
(A) Representative plots (left) and graph depicting the frequency of SPF microbiot
of a pool of three replicates from two independent experiments.
(B) Analysis by stimulated emission depletion super-resolution microscopy of SP
hFc. Scale bar, 2 mm.
(C) Frequency of SPF-mouse luminal and mucosal microbiota stained with contr
(D) Luminal microbiota was stained as in (A), sorted into Mincle-hFc-enriched
(control-hFc+) fractions, and analyzed by 16S sequencing. Shown on the left is the
right are the enrichment index and specificity index, calculated as explained in th
(E) Mucosa-associated commensals from WT SPF mice gavaged with Celltr
L. plantarum were stained with control-hFc or Mincle-hFc and analyzed by flow cy
frequency of bacteria positive for the indicated staining and pre-gated on cell-vio
(F) Mincle expression in PPs from Mincle-deficient (Clec4e/) mice and WT litte
(G) Mincle expression in the indicated genotypes by flow cytometry in PPs. On th
is shown.
(H) Mincle expression by flow cytometry in the myeloid populations fromWT mice
cells in the depicted subset is shown.
(I) Frequency of Mincle+ cells in the myeloid subsets from WT small intestine LP.
(J) Mincle expression in LP mononuclear cells from three colonic and three duode
strategy is shown. In the middle, Mincle versus fluorescence minus one (FMO) ex
Shown on the right is the MFI of Mincle expression or the FMO in six independe
Data represent one representative experiment of two performed (B, C, E, F, and
*p < 0.05, **p < 0.01 (unpaired two-tailed Student’s t test). See also Figure S2.
450 Immunity 50, 446–461, February 19, 2019from PPs to prime OT-II CD4+ T cells ex vivo. Dome CD11b+
DCs and LysoDCs had a higher capacity to induce IL-17 produc-
tion by CD4+ T cells than did CD8a+ DCs and LysoMacs (Fig-
ure 3A). Moreover, the ability of CD11b+ DCs and LysoDCs to
promote Th17 differentiation was dependent on Mincle and
Syk (Figures 3A–3C, S3A, and S3B), whereas Th1 differentiation
induced by these cells wasMincle and Syk independent (Figures
S3C and S3D). These results suggest that dome CD11b+ DCs
and LysoDCs located in PPs mediate Mincle- and Syk-depen-
dent Th17 differentiation.
Mincle Fosters IL-6 and IL-23p19 Production by DCs in
Response to Microbiota
The cytokine IL-6 plays a non-redundant role in Th17 differentia-
tion in gut mucosa (Hu et al., 2011; Persson et al., 2013), and
CD11b+ DCs from PPs are better at producing IL-6 than other
DC subsets from PPs or splenic DCs (Sato et al., 2003).
Conversely, activation of ILC3s is independent of IL-6 but
dependent on microbiota-induced IL-23p19 (Klose and Artis,
2016). Therefore, we explored whether both instructing signals
are produced in a Mincle-dependent manner in PPs. Mincle-
deficient mice exhibited reduced IL-6 and IL-23p19, but their
TGF-b and IL-12p40 transcripts in PPs were similar to those in
WT littermates (Figure 3D). Consistent with this, IL-6 production
by CD19CD11c+MHCII+ DCs in PPs was diminished in Mincle-
deficient mice compared with WT littermates, whereas IL-12p40
production was not affected (Figures 3E, 3F, and S3E). Accord-
ingly, microbiota induced Mincle-dependent IL-6 and IL-23 pro-
duction by GM-DCs (Figure 3G). These results indicate that the
steady-state microbiota triggers Mincle-dependent IL-6 and
IL-23p19 expression, which could instruct IL-17 and IL-22
production.
Mincle and Syk in DCs Are Needed for Intestinal IL-17
and IL-22 Production
Because CD11cDSyk mice selectively deplete Syk in spleen
CD11c+ cells, but not in B or T cells (Whitney et al., 2014), wepressing Mincle
a stained with control-hFc or Mincle-hFc. Shown is the arithmetic mean + SEM
F-mouse mucosa-associated commensals labeled with control-hFc or Mincle-
ol-hFc or Mincle-hFc by flow cytometry.
(Mincle-hFc+), Mincle-hFc-depleted (Mincle-hFc), and control-hFc-enriched
relative abundance of each genus from two independent experiments. To the
e STAR Methods.
ace-violet-labeled Lactobacillus plantarum (L. plantarum) or in-vitro-grown
tometry. Shown on the left is representative staining. Shown on the right is the
let-positive bacteria.
rmates analyzed by qPCR and normalized to Gapdh.
e left are representative plots. On the right, mean fluorescence intensity (MFI)
PPs. On the left is a representative plot. On the right, the frequency of Mincle+
nal samples from healthy individuals by flow cytometry. On the left, the gating
pression in the CD11cHLA-DR and CD11c+HLA-DR+ populations is shown.
nt samples.
J) or were pooled from at least two independent experiments (G, H, and I).
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Figure 3. DCs from PPs Instruct Mincle- and Syk-Dependent Th17 Differentiation
(A–C) Naive OT-II T cells were co-cultured for 3 days with domeCD11b+ DCs, CD8a+ DCs, LysoMacs, or LysoDCs from the indicated genotypes, sorted fromPPs
(1:1 ratio), and loaded with OVA323–339 peptide. (A) IL-17 secretion by ELISA. Each dot represents an independent co-culture where myeloid cells were from
different mice from two independent experiments. (B and C) Representative FACS plots of IL-17 (B) and IL-22 (C) intracellular staining after OTII re-stimulation.
(D) Il6, Il23a, Tgfb, and Il12b transcripts in PPs of the indicated genotypes by qPCR; they were normalized to Gapdh.
(E and F) Analysis of IL-6 (E) and IL-12p40 (F) intracellular staining in CD11c+MHC-II+CD19 cells from PPs in the indicated genotypes. Shown on the left are
representative histograms. On the right is MFI of staining.
(legend continued on next page)
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explored whether the absence of Mincle and Syk in the CD11c+
compartment could affect Th17 differentiation in the steady-
state intestine in vivo. IL-17 and IL-22 production by both
CD4+ T cells from PPs and sorted CD3+ T cells from the small in-
testine LP was reduced both in CD11cDSyk mice (Figures 4A
and S4A) and in Mincle-deficient mice (Figures 4B and S4B)
compared with WT littermates, whereas IFN-g production was
not altered (Figures 4C, 4D, and S4C). IL-17-producing T cells
generated in a Mincle-dependent manner in the steady state
mainly co-produced IL-10, but not IFN-g, indicating that these
T cells were non-pathogenic (Figure 4E) (McGeachy et al., 2007).
The frequencies of T cells in PPs and small intestine LP in the
absence of Mincle and Syk were comparable to those of WT lit-
termates (Figures S4D and S4E). Naive CD4+ T cells from both
CD11cDSyk and Mincle-deficient mice differentiated normally
into IL-17- and IL-22-secreting effector cells in the presence of
Th17-polarizing cytokines (Figure S4F). Furthermore, adoptively
transferred naive CD4+ T cells from CD11cDSyk mice or WT lit-
termates (CD45.2+) similarly produced IL-17 and IL-22 in PPs
of WT recipients (CD45.1) (Figure S4G). These results exclude
an intrinsic defect of cytokine production in the T cells of
these mice.
Additional sources of IL-17 and IL-22 in the gut are CCR6-ex-
pressing ILC3s that are mainly located in PPs (Klose and Artis,
2016). CD11cDSyk and Mincle-deficient mice exhibited fewer
IL-17- or IL-17- and IL-22-producing ILCs both in PPs and in
small intestine LP than didWT littermates, whereas ILCs produc-
ing only IL-22 were comparable between genotypes (Figures 4F,
4G, S4H, and S4I). Frequencies of CCR6+ ILCs in PPs or
CD3CD90.2+ ILCs from the small intestine in the absence of
the Mincle-Syk pathway were comparable to those in WT litter-
mate controls (Figures S4J and S4K). These results reveal that
the Mincle-Syk signaling pathway regulates IL-17 and IL-22 pro-
duction by both innate and adaptive cellular sources in the
steady-state small intestine and PPs.
Mincle-Dependent IL-17-ProducingCells in PPsRequire
Commensal Bacteria
Treatment with a broad-spectrum antibiotic cocktail to disrupt
the gut microbiota abolished IL-17 production by T cells from
PPs in WT littermates to the levels found in Mincle-deficient
and CD11cDSyk mice (Figures 5A and S5A), suggesting that
PP Th17 cell development requires intestinal bacteria. Given
the prominent role of SFB in Th17 cell differentiation in PPs (Iva-
nov et al., 2009), we investigated the potential involvement of
SFB in the Mincle-dependent Th17 differentiation. SFB were de-
tected in our mouse colonies by PCR (IDEXX Bioresearch).
Consistently, Saa1 ileal transcripts, which are linked to SFB
presence (Ivanov et al., 2009), were found in our mouse colonies
and even increased in the absence of the Mincle-Syk pathway
(Figure S5B). SFB are sensitive to vancomycin treatment (Ivanov
et al., 2008), as we demonstrated in our model by the reduction
of the Saa1 ileal transcripts and the decrease in SFB content in
feces after treatment (Figures S5C and S5D). Notably, vancomy-(G) ELISA of IL-6 and IL-23 production by sorted GM-DCs from WT and Mincle-d
(10:1 DC ratio) for 12 h.
Data represent two independent pooled experiments (A) or one representative e
(A: one-way ANOVA and Bonferroni post hoc test; D, E, and G: unpaired two-tai
452 Immunity 50, 446–461, February 19, 2019cin treatment slightly reduced IL-17 production by CD4+ T cells
from PPs of WT littermates, but the remaining IL-17 production
was dependent on Mincle (Figure 5B). Mincle-independent
IFN-g production by PP CD4+ T cells was not affected by
vancomycin treatment (Figure S5E). These results show that
vancomycin-resistant bacteria mediate Mincle-dependent
IL-17 production by T cells from PPs.
Given the binding ofMincle-hFc to L. plantarum (Figure 2E), we
tested the ability of mucosal-associated commensals from WT
mice treated with ABX during gestation and lactation and gav-
aged with L. plantarum at weaning (L. plantarum-enriched
mucus) to induce Th17 differentiation in vitro. For this, we stimu-
lated naive OT-II T cells with sorted WT and Mincle-deficient
(Clec4e/) GM-DCs loaded with OVA323–339 peptide and pulsed
or not (medium) with L. plantarum-enriched mucus. We found
that L. plantarum-enriched mucus induced IL-17 and IL-22
production by naive OT-II cells upon culture with WT but not
Mincle-deficient GM-DCs (Figures 5C and S5F), whereas IFN-g
production was similar between both genotypes (Figure S5G).
Induction of Th17 differentiation correlated with Mincle-depen-
dent production of IL-6 and IL-23 by GM-DCs (Figure 5D). More-
over, compared with controls not gavaged with L. plantarum,
mice treatedwith ABX and gavagedwith L. plantarum at weaning
as indicated above showed a Mincle-dependent induction of
IL-17 and IL-22 production by CD4+ T cells and CCR6+ ILCs in
PPs (Figures 5E and 5F) without affecting IFN-g production (Fig-
ure S5H). These results suggest that mucosa-associated bacte-
ria, including L. plantarum, drive Mincle-dependent IL-17- and
IL-22-producing cells in PPs.
The Mincle-Syk Axis Contributes to Intestinal Barrier
Function
We next explored whether the defective IL-17 and IL-22 expres-
sion in Mincle-deficient and CD11cDSyk mice affects intestinal
barrier function. To assess the physical intestinal barrier integrity,
we administered FITC-dextran by oral gavage and found that
Mincle-deficient mice and WT littermates had similar serum
FITC concentration at different time points (Figure S6A). To
explore the immunological barrier, we examined the expression
of intestinal antimicrobial peptides, specifically RegIIIg, whose
production relies on RORgt-dependent cells (Sanos et al.,
2009). We found that steady-state Reg3g expression was
reduced in the absence of Mincle or Syk in CD11c+ cells
compared with WT cells (Figure 6A). Notably, oral administration
of L. plantarum to ABX-treated weanedmice as above promoted
Reg3g expression in a Mincle-dependent manner (Figure 6B).
IgA secretion can be influenced directly by Th17 cells and
ILC3s (Hirota et al., 2013; Kruglov et al., 2013). Total IgA was
reduced in the intestinal lumen in Mincle-deficient and
CD11cDSyk mice compared with WT littermate controls (Fig-
ure 6C). Remarkably, Mincle deficiency decreased the genera-
tion of IgA against gut-microbiota-specific antigens, such as
LPS and flagellin (Figure S6B). Flow-cytometry analysis of
the frequency of IgA-coated intestinal bacteria, which waseficient (Clec4e/) mice untreated (medium) or stimulated with gut microbiota
xperiment of at least two performed (B–G). *p < 0.05, **p < 0.01, ***p < 0.001
led Student’s t test). See also Figure S3.
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Figure 4. Mincle and Syk in DCs Are Needed for Intestinal IL-17 and IL-22 Steady-State Production
(A–E) Representative plots and summary graph of IL-17 and IL-22 (A and B), IFN-g (C and D), and IL-17, IFN-g, and IL-10 (E) production by intracellular staining
after phorbol 12-myristate 13-acetate (PMA) and ionomycin stimulation in CD4+ T cells from PPs in the indicated genotypes.
(F and G) Frequency of CCR6+ ILCs from PPs producing IL-22 and IL-17 in the steady state by intracellular staining in the indicated genotypes.
At least two independent experiments were pooled. Each symbol represents an individual mouse. The arithmetic mean for each group is indicated. **p < 0.01,
***p < 0.001 (unpaired two-tailed Student’s t test). See also Figure S4.
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Figure 5. Commensal Bacteria Are Required for Mincle-Dependent Th17 Generation in PPs
(A and B) Frequency of IL-17 production by intracellular staining in re-stimulated CD4+ T cells from PPs of the indicated genotypes after treatment with an
antibiotic cocktail (ABX) containing ampicillin, neomycin, metronidazole, and vancomycin (A) or vancomycin only (B) in the drinking water over 4 weeks.
(C) Frequency of IL-17 and IL-22 production by intracellular staining of re-stimulated OT-II T cells co-cultured with sorted WT and Mincle-deficient (Clec4e/)
GM-DCs loaded with OVA323–339 peptide, as in Figures 1D and 1E; the cells were pulsed or not (medium) with mucosal-associated commensals from WT mice
treated with ABX during gestation and lactation and gavaged with L. plantarum at weaning as indicated (L. plantarum-enriched mucus; 10:1 DC ratio).
(D) ELISA of IL-6 and IL-23 from the co-culture of GM-DC in (C).
(legend continued on next page)
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dependent on Aicda, revealed a specific reduction of IgA in the
absence of Mincle (Figures 6D and S6C). Frequency of IgA+
plasma cells in the small intestine LP of Mincle-deficient and
CD11cDSyk mice was lower than in WT littermates (Figures 6E
and S6D), and IgG+ plasma cells were similar (Figure 6F). This
correlated with reduced percentages of PD-1highCD4+ T cells
in PPs (Figures 6G and S6E), a marker of T follicular helper
(Tfh) cells, which are a T cell subset that promotes IgA-producing
germinal center B cells (Hirota et al., 2013). These differences in
gut immunity did not result in significant differences in the luminal
microbiota composition at the genus level between Mincle-defi-
cient mice and their WT littermates (Figure S6F). These results
indicate that the Mincle-Syk signaling pathway contributes to
maintaining a functional intestinal immune barrier but does
not play a major role in regulating intestinal microbiome
composition.
The Mincle-Syk Pathway Promotes Commensal
Bacteria Containment
To explore whether the functional impairment of the intestinal
barrier in Mincle-deficient and CD11cDSyk mice affects micro-
bial containment in the intestine, we first analyzed the presence
of live facultative aerobe bacteria in extra-intestinal organs. We
found increasedmicrobe translocation to the liver in Mincle-defi-
cient or CD11cDSyk mice compared with littermate controls
(Figures 7A and S7A). Deep 16S rRNA sequencing revealed
that most of the surplus disseminated aerobe bacteria found in
the liver ofMincle-deficient mice belonged to the phylum Proteo-
bacteria either after growth in lysogeny broth (LB) or by direct
sequencing of fresh liver homogenates (Figure 7B). As an addi-
tional readout for systemic dissemination of commensals
(Zeng et al., 2016), we found increased intestinal-bacteria-spe-
cific IgG in the sera of Mincle-deficient and CD11cDSyk mice
compared with WT littermates (Figures 7C and S7B).
Next, we analyzed whether the presence of increased intesti-
nal commensals in the liver of Mincle-deficient mice can lead to
patho-physiological alterations. CD45+CD11bhigh myeloid cells,
mainly neutrophils and inflammatorymonocytes, were increased
in the liver of Mincle-deficient mice compared with WT litter-
mates in an ABX-dependent manner (Figures 7D and S7C). Liver
inflammation in the absence of Mincle correlated with moderate
liver malfunction reflected by an increased total, but not direct,
serum bilirubin (Figure 7E) without affecting serum levels of
alanine aminotransferase (ALT) or aspartate aminotransferase
(AST) (Figure S7D). The expression of some lipid-metabolism-
related genes, such as Scd1 (stearoyl-CoA desaturase-1) or
Cpt1a (carnitine palmitoyltransferase 1), was significantly
increased in the liver of Mincle-deficient mice (Figure 7F). This
augmented expression of lipogenic genes correlated with an
accumulation of diacylglycerides (DAGs) (Figure 7G) and some
fatty acids, including margaric and linoleic acids, in Mincle-defi-
cientmice (Figure 7H), as revealed bymetabolomics assays (Fig-(E and F)WT littermates andMincle-deficient (Clec4e/) mice were treatedwith A
at weaning (+ L. plantarum gavage) or not (WT), as indicated in the figure. The fre
ILCs (F) from PPs by intracellular staining in the indicated genotypes and conditi
Data represent one representative experiment of two performed (A and F) or w
represents an individual mouse. The arithmeticmean for each group is indicated. *
test; F: unpaired two-tailed Student’s t test). See also Figure S5.ure S7E). These results indicate that the intestinal immune barrier
fostered by the Mincle-Syk axis limits microbial translocation,
preventing systemic inflammation and promoting host-micro-
biota mutualism.
DISCUSSION
IL-17 and IL-22 contribute to intestinal barrier function in
response to microbiota, regulating the expression of antimicro-
bial peptides and mucin genes and influencing IgA responses
(Hirota et al., 2013; Kruglov et al., 2013). However, the host re-
ceptors and signaling pathways that link intestinal microbiota
with regulation of IL-17 and IL-22 production to maintain a ho-
meostatic host-microbiota relationship need to be further
explored. Here, we provide evidence that the sensing of
mucosal-associated bacteria by the Mincle-Syk signaling axis
in LysoDCs and dome CD11b+ DCs in PPs induces IL-6 and
IL-23, cytokines that stimulate intestinal T cells and ILCs to pro-
duce IL-17 and IL-22. Defective IL-17 and IL-22 production in
the absence of a functional Mincle-Syk axis in DCs was associ-
ated with impaired intestinal immune barrier function, resulting
in increased systemic translocation of microbiota, hepatic
inflammation, and metabolic alterations. We found that Syk ki-
nase, but not MyD88, behaved as a non-redundant innate
signal for driving Th17 differentiation in response to gut micro-
bial recognition by DCs. This is consistent with previous studies
revealing a critical role for MyD88 signaling in T cells, but not in
DCs, in Th17 commitment (Hu et al., 2011; Shaw et al., 2012).
The Syk pathway is utilized by several CLRs, which play impor-
tant roles in bridging innate and adaptive immunity after infec-
tion whereby they prominently modulate Th17 effector cell
generation (Geijtenbeek and Gringhuis, 2016; LeibundGut-
Landmann et al., 2007). Remarkably, Mincle-deficient mice
phenocopied all defects observed in CD11cDSyk mice, indi-
cating that Mincle is most likely upstream of Syk in CD11c+ cells
inducing IL-17 and IL-22 production in response to intestinal mi-
crobiota, although additional receptors sensing microbiota
could trigger Syk.
The differential spatial distribution of commensal microbes in
the intestine influences their capacity to shape host immune re-
sponses (Atarashi et al., 2015; Fung et al., 2014; Ivanov et al.,
2008). Our results suggest a preferential location of commensal
bacteria containing Mincle ligands close to the intestinal mu-
cosa. The 16S rRNA sequencing of bacteria enriched by the
extracellular domain of Mincle indicates that the small-intes-
tine-adherent Lactobacillus (Donaldson et al., 2016) contains a
ligand for Mincle. Intriguingly, exposition of the ligand seems to
require transit through the intestine, resembling the described
structural adaptations in the cell-surface composition of bacteria
upon different environmental situations (Sengupta et al., 2013).
Our results concur with an L. plantarum-derived glycolipid that
signals through Mincle (Shah et al., 2016) and with previousBX during gestation and lactation andwere gavagedwith L. plantarum (13 106)
quency of IL-17- and IL-22-producing re-stimulated CD4+ T cells (E) or CCR6+
ons is shown.
ere pooled from at least two independent experiments (B–E). Each symbol
p < 0.05, **p < 0.01, ***p < 0.001 (A–E: one-way ANOVA and Bonferroni post hoc
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Figure 6. The Mincle-Syk Axis Contributes to Intestinal Barrier Function
(A and B) Reg3g transcripts were measured by qPCR and normalized to Gapdh in the jejunum of the indicated genotypes during the steady state (A) or after
L. plantarum gavage, as described in the scheme (B).
(C) Quantification of total IgA measured by ELISA in the intestinal lumen of the indicated genotypes.
(D) Frequency of IgA+ bacteria by flow cytometry in the indicated genotypes.
(E and F) Representative plots and summary graphs of CD45+B220IgA+ (E) or IgG+ (F) plasmatic cells from the small intestine LP of Mincle-deficient (Clec4e/)
mice and WT littermate controls.
(G) Representative plots and summary graph of CD4+PD-1high T cells from PPs of the indicated genotypes.
Data were pooled from at least two independent experiments. Individual mice and the arithmetic mean of each group are indicated. *p < 0.05, **p < 0.01,
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Figure 7. Mincle-Syk Pathway Promotes Commensal Bacteria Containment
(A) Bacterial translocation into the liver of Mincle-deficient (Clec4e/) mice andWT littermates. On the left is the bacterial load as colony-forming units (CFUs) per
organ, indicating the limit of detection (LOD). On the right, the frequencies of the mice of each genotype show more than 40 CFUs per organ (23 LOD).
(B) 16S rRNA sequencing analysis of LB-grown commensals from the liver (left) or bacterial DNA directly extracted from the liver (right) in the indicated genotypes.
The graph shows the percentage of total reads corresponding to each phylum. Each bar represents four pooled LB plates per mouse and four mice per sample of
each genotype (LB-grown commensals) or six pooled mice per genotype (commensals from the liver).
(C) ELISA of serum IgG against intestinal bacteria in the indicated genotypes.
(D) Total numbers of CD45+CD11bhigh cells infiltrated in the liver of the indicated genotypes in the steady state or after administration of an antibiotic cock-
tail (ABX).
(E) Total (left) or direct (right) bilirubin in the indicated genotypes.
(F) Acc, Fas, Scd1, Srebpc, G6pase, Pepck, Cpt1a, and Ppara transcripts from the liver of 15 mice of the indicated genotypes were analyzed by qPCR and
normalized to Gapdh in three independent experiments; the graph shows fold induction compared with the WT.
(G and H) Individual lipid species of diacylglycerides (DAGs) (G) and the margaric (C17:0) and linoleic (C18:2) acid classes of free fatty acids (H) measured by a
liquid chromatography-mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS) metabolomics-based profiling approach. Data are
presented as the metabolites’ abundance.
Data were pooled from at least two independent experiments. Individual mice and the arithmetic mean of each group are shown (A, C–E, G, and H). *p < 0.05,
**p < 0.01, ***p < 0.001 (A–C and E–H [margaric acid]: unpaired two-tailed Student’s t test; H [linoleic acid]: Mann-Whitney U test; D: one-way ANOVA and
Bonferroni post hoc test). See also Figure S7.reports indicating that Lactobacillus activates Syk in DCs (Weiss
et al., 2012).
Some Lactobacillus species have preferential association with
the follicle-associated epithelium of PPs (Plant and Conway,
2001). We showedMincle expression in LysoDCs and LysoMacsand, to a lesser extent, in dome CD11b+ DCs. Thesemyeloid cell
subsets are efficient in the capture of antigens and essential to
driving the generation of themucosal immune response (Da Silva
et al., 2017).We found that domeCD11b+DCs and LysoDCs, but
not LysoMacs, from PPs induced Th17 cell differentiation fromImmunity 50, 446–461, February 19, 2019 457
naive T cells in a Mincle- and Syk-dependent fashion, consistent
with their T cell priming capacity (Da Silva et al., 2017). Consis-
tent with this, Mincle expression by DCs, but not macrophages,
contributes to the generation of splenic immunity during Myco-
bacterium bovis infection in mice (Behler et al., 2015).
The intestinal microbiota is critical for IL-17 and IL-22 produc-
tion by RORgt-dependent cells, and SFB are a key example
(Atarashi et al., 2015; Gaboriau-Routhiau et al., 2009; Ivanov
et al., 2008; Ivanov et al., 2009; Sano et al., 2015; Sawa et al.,
2010). Vancomycin-resistant intestinal bacteria promoted
Mincle-dependent Th17 generation in PPs, suggesting that it is
at least partially independent of SFB. However, we cannot rule
out that SFB launched a Th17 response that can be maintained
by other vancomycin-resistant mucosa-associated bacteria
after vancomycin administration, as suggested previously (Le´-
cuyer et al., 2014).
In contrast, L. plantarum, which possesses a ligand for Mincle
(Shah et al., 2016), was able to induce Mincle-dependent Th17
differentiation both in vitro and in ABX-treated mice. Mechanisti-
cally, IL-6 from CD103+CD11b+ DCs is key for Th17 differentia-
tion in the intestine (Persson et al., 2013; Schlitzer et al., 2013).
Compared with other DC subsets in PPs and spleen (Sato
et al., 2003), LysoDCs and dome CD11b+ DCs from PPs are a
major source of IL-6 (Da Silva et al., 2017). Our data indicate
that Mincle contributes to IL-6 and IL-23p19 production by
PPs DCs, which might explain the selective effect in the differen-
tiation of Th17 but not Th1 cells. On the other hand, the regula-
tion of IL-23p19 might affect ILC function, which requires
IL-23R signaling for IL-22 and/or IL-17 secretion (Longman
et al., 2014; Satpathy et al., 2013). The mucosal localization of
Lactobacillus could underlie its role as a relevant conditioning
factor for DCs in the PPs, but other bacteria genera at different
locations might also condition the immune response locally or
even systemically.
We found that reduced production of IL-17 and IL-22 in the
absence of the Mincle-Syk axis in CD11c+ cells led to impaired
Reg3g expression, which is regulated by IL-22 (Sanos et al.,
2009). Impaired IgA generation correlated with a reduction in
the frequency of IgA+ plasma cells in the small intestine LP
and the proportion of CD4+PD-1high cells, which mark Tfh cells,
in PPs in the absence of Mincle and Syk in CD11c+ cells. Tfh
differentiation requires interaction with CD11b+ DCs and IL-6
for Bcl-6 expression (Krishnaswamy et al., 2017). Reduced
IL-6 production by CD11b+ DCs, together with the contribution
of the Th17 cell differentiation into Tfh in PPs (Hirota et al.,
2013), could contribute to the defective IgA generation in the
absence of Mincle. However, these differences in gut immunity
did not result in significant differences in the luminal microbiota
composition between Mincle-deficient mice and their WT litter-
mates, although there could be regional changes in microbiota
composition. For instance, Reg3g deficiency causes signifi-
cant differences in mucosa-associated bacteria, but not in
the composition of luminal bacterial communities. (Vaishnava
et al., 2011).
We found that IL-17 and IL-22 deficiency correlated with
increased peripheral dissemination of commensal bacteria
and, in turn, with serum commensal-specific IgG antibodies,
consistent with previous results (Lochner et al., 2011; Sonnen-
berg et al., 2012). Commensal translocation correlated with458 Immunity 50, 446–461, February 19, 2019higher liver infiltration of neutrophils and monocytes in Mincle-
deficient mice, concurring with a recent report indicating that
Lactobacillus-dependent IL-22 secretion by ILCs can prevent
liver inflammation by promoting the intestinal barrier (Nakamoto
et al., 2017). Liver inflammation was associated with moderate
liver malfunction reflected systemically by an increased total
serum bilirubin and by the accumulation of DAG and some fatty
acids in the liver of Mincle-deficient mice. These results suggest
a putative link between commensal-driven inflammation and
hepatic lipid metabolism, consistent with previous studies
indicating that increased intestinal permeability, bacterial trans-
location, and subsequent inflammation can affect hepatic meta-
bolism (Pierantonelli et al., 2017; Talukdar et al., 2012).
Our findings establish that Mincle and Syk signaling couples
the sensing of mucosa-associated bacteria by DCs in PPs with
the production of IL-6 and IL-23, cytokines that regulate IL-22
and IL-17 production through T cells and ILCs. This interaction
promotes the intestinal immune barrier, limiting microbial trans-
location and preventing systemic inflammation and its metabolic
consequences. The elucidation of this new host-commensal
mechanism of interaction, which is essential to maintaining the
homeostatic host-microbiota mutualism, has potential implica-
tions for diseases associated with increased bacterial transloca-
tion, such as metabolic disorders.STAR+METHODS
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anti-mouse CD115 (c-fms), biotin, clone AFS98 ThermoFisher Cat# 13-1152-81; RRID: AB_466563
anti-mouse Mincle, clone 1B6 MBL Cat# D266-3B; RRID: AB_10950261
Rat IgG1, k Isotype Control Antibody, biotin, clone RTK2071 BioLegend Cat# 400403; RRID: AB_326509
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anti-mouse IL-6, clone MP5-20F3 BD Biosciences Cat# 554400; RRID: AB_398549
anti-mouse IL-6, biotin, clone MP5-32C11, ThermoFisher Cat# 13-7062-81; RRID: AB_466910
anti-mouse IgA, polyclonal Bethyl Cat# A90-103A; RRID: AB_67136
mouse IgA, k Isotype Control, clone M18-254 BD Biosciences Cat# 553476; RRID: AB_479590
anti-mouse IgA, HRP, polyclonal SouthernBiotech Cat# 1040-05; RRID: AB_2714213
anti-mouse IgG-heavy and light chain, HR, polyclonal Bethyl Cat# A90-216P; RRID: AB_67184
anti-mouse CD25, biotin, clone PC61 BioLegend Cat# 102004; RRID: AB_312853
anti-mouse CD44, biotin, clone IM7 BioLegend Cat# 103004; RRID: AB_312955
Bacterial and Virus Strains
Lactobacillus plantarum (Lp 39 [IAM 12477]) ATCC ATCC14917
Biological Samples
Healthy adult intestine tissue Hospital Universitario de La
Princesa (Madrid, Spain)
N/A
Chemicals, Peptides, and Recombinant Proteins
Liberase TM Research Grade Sigma-Aldrich Cat# 5401119001
DNase I, Bovine Pancreas, > 2000U/MG Biomatik Cat# A4193
Collagenase from Clostridium histolyticum, type 4 Sigma-Aldrich Cat# C5138
Collagenase, Type 2 Worthington Cat# LS004176
Collagenase D from Clostridium histolyticum Sigma-Aldrich Cat# 11088858001
CellTrace Violet Cell Proliferation Kit Invitrogen Cat# C34557
Recombinant murine GM-CSF Miltenyi Biotec Cat# 130-095-746
Trehalose-6,6-dibehenate (TDB) Mincle Agonist InvivoGen Cat# tlrl-tdb
Phorbol 12-myristate 13-acetate (PMA) Sigma-Aldrich Cat# P8139
Ionomycin calcium salt Sigma-Aldrich Cat# I0634
Recombinant Mouse TGF-b BioLegend Cat# 763102
Recombinant Mouse IL-6 BioLegend Cat# 575702
Recombinant Mouse IL-23 BioLegend Cat# 589002
Streptavidin APC eBioscience Cat# 17-4317-82
Streptavidin PE eBioscience Cat# 12-4317-87
Streptavidin PerCP-Cyanine5.5 eBioscience Cat# 45-4317-82; RRID: AB_10311495
Streptavidin BV786 BD Biosciences Cat# 563858
LIVE/DEAD Fixable Near-IR Dead Cell Stain Kit Molecular Probes Cat# 10154363
Hoechst 33258 ThermoFisher Cat# H3569; RRID: AB_2651133
Mincle (Clec4e)-human Fc Chimera protein Iborra et al., 2016, this paper N/A
Dectin-1(Clec7a)-human Fc Chimera protein Iborra et al., 2016, this paper N/A
Recombinant Human CLEC4E Fc Chimera Protein R&D Cat# 8995-CL-050
Recombinant Human IgG1 Fc Protein R&D Cat# 110-HG-100; RRID: AB_276244
Recombinant Human Dectin-2/CLEC6A Protein R&D Cat# 3114-DC-050
SYTO 61 Red Fluorescent Nucleic Acid Stain ThermoFisher Cat# S11343
Cimetidine hydrochloride Sigma-Aldrich Cat# 70059-30-2
Sincalide Tebu-bio Cat# HOR-274
Poly-L-lysine hydrobromide Sigma-Aldrich Cat# P1524
Streptavidin, Alexa Fluor 488 ThermoFisher Cat# S11223; RRID: AB_2336881
DAPI (4’,6-Diamidino-2-Phenylindole, Dihydrochloride) ThermoFisher Cat# D1306; RRID: AB_2629482
SureBlue TMB 1- Peroxidase Substrate SeraCare Cat# 5120-0075
TMB Stop Solution SeraCare Cat# 5150-0020
Ampicilin (Gobemicin) Normon Cat# 882829.6
Neomycin Sulfate Sigma-Aldrich Cat# 1405-10-3
Metronidazole (Flagyl) Sanofi Cat# 667717.9
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Vancomycin Normon Cat# 850941.6
Sucralose Sigma-Aldrich Cat# 56038-13-2
Fluorescein isothiocyanate–dextran Sigma-Aldrich Cat# 46944
Critical Commercial Assays
Biotinylation Kit Abcam Cat# ab201795
Bacteria Counting Kit ThermoFisher Cat# B7277
RNeasy Mini Kit QIAGEN Cat# 74104
High-Capacity cDNA Reverse Transcription Kit Applied Biosystems Cat# 4368814
GoTaq qPCR Master Mix Promega Cat# A6001
Tyramide signal amplification (TSA) detection kit Alexa
Fluor 568
Molecular Probes Cat# T20949
Mouse IL-17A (homodimer) ELISA Ready-SET-Go Affymetrix Cat# 88-7371
Mouse IFN-g ELISA Set BD Biosciences Cat# 555138
QIAamp PowerFecal Pro DNA Kit QIAGEN Cat# 51804
Zero Blunt TOPO PCR Cloning Kit ThemoFisher Cat# K280002
Ultra-Deep Microbiome Prep Molzym Cat# G-030-050
QIAamp DNA Mini Kit QIAGEN Cat# 51304
QIAamp DNA Stool Mini Kit QIAGEN Cat# 51504
2x Kapa HiFi Hot Start Ready Mix Kapa Biosystems Cat# KK5702
Nextera XT DNA Library Preparation Kit Illumina Cat# FC-131-1024
Experimental Models: Organisms/Strains
Mouse: Clec4e/ (B6.Cg-Clec4etm1.1Cfg) Wells et al., 2008 N/A
Mouse: CD11cDSyk (B6.Cg-Tg(Itgax-cre)1-1Reiz/J
Syktm1.2Tara/J)
Iborra et al., 2012 N/A
Mouse: OT-II (B6.Cg-Tg (TcraTcrb) 425Cbn/J) Jackson Laboratory Cat# 004194
Mouse: Rorc/ (B6.Cg -Rorctm1Litt/J) Sun et al., 2000 N/A
Mouse: Aicda / (C57BL/6 Aicdatm3.1Mnz/J) Revy et al., 2000 N/A
Oligonucleotides
Primers for qRT-PCR, see Table S1 This paper N/A
Software and Algorithms
FlowJo v10 Tree Star https://www.flowjo.com/solutions/
flowjo/downloads
BaseSpace Application 16S Metagenomics v1.0 Illumina https://support.illumina.com/downloads/
local-run-manager-16s-metagenomics-
module.html
Quantitative Insights into Microbial Ecology v1.9.0 (QIIME) Caporaso et al., 2010 http://qiime.org/
GraphPad Prism v5 GraphPad Software N/A
Other
Streptavidin MicroBeads Miltenyi Biotec Cat# 130-048-101
Anti-mouse CD11c MicroBeads Miltenyi Biotec Cat# 130-097-059
LPS-EB Ultrapure (Ultrapure LPS, E. coli 0111:B4) InvivoGen Cat# tlrl-3pelps
Zymosan InvivoGen Cat# tlrl-zyn
Brefeldin A Sigma-Aldrich Cat# B7651
Anti-PE MicroBeads Miltenyi Biotec Cat# 130-048-801; RRID: AB_244373
ProLong Gold Antifade Mountant Life Technologies Cat# P36930
Standard flagellin from S. typhimurium InvivoGen Cat# tlrl-stfla
AMPure XP beads Beckman Coulter Cat# A63882
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, David
Sancho (dsancho@cnic.es). Themouse lines obtained from other laboratories are described below andmay require aMaterial Trans-
fer Agreement (MTA) with the providing scientists.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Experimental Animals
Micewere bred andmaintained in groups of 2-5 animals per cage at the CNIC under specific pathogen-free conditions. Unless other-
wise stated, males and females of 7-9 weeks old were used. Animal studies were approved by the local ethics committee. All animal
procedures conformed to EU Directive 2010/63EU and Recommendation 2007/526/EC regarding the protection of animals used for
experimental and other scientific purposes, enforced in Spanish law under Real Decreto 1201/2005.
Colonies included Clec4e/ (B6.Cg-Clec4etm1.1Cfg) mice backcrossed more than 10 times to C57BL/6J-Crl were kindly provided
by the Scripps Research Institute, through R. Ashman and C. Wells (Griffiths University, Australia) (Wells et al., 2008). CD11cDSyk
(Iborra et al., 2012; Whitney et al., 2014) and Clec4e/ mice were generated along with WT littermates by heterozygous matings.
OT-II CD4+ TCR transgenic mice in C57BL/6 background (B6.Cg-Tg (TcraTcrb) 425Cbn/J) were from The Jackson Laboratory.
OT-II mice were mated with B6/SJL expressing the CD45.1 congenic marker (The Jackson Laboratory) to facilitate cell tracking.
Rorc/ mice (Sun et al., 2000) and Aicda/ mice (Revy et al., 2000) were kindly provided by Dr. B. Becher (UZH, Switzerland)
and Dr. A. Ramiro (CNIC, Spain), respectively. All the mice were backcrossed more than 10 generations to C57BL/6J-Crl.
Human samples
Human intestinal samples were obtained from healthy controls (3 male age 43, 26, 59; 3 female age 26, 48, 58) with no known auto-
immune diseases ormalignancies who had been referred to the endoscopy unit for screening of gastrointestinal diseases, although in
all cases they had macroscopically and histologically normal (non-inflamed) intestines. Samples were obtained following informed
consent after ethical approval (BER-CDEII-2015) from Hospital Universitario de La Princesa (Madrid, Spain).
Microbe strains
For the indicated experiments, Lactobacillus plantarum (ATCC14917) was grown overnight on MRS Broth medium (Oxoid) at 37C in
aerobic conditions to approximately OD600nm of 0.5
METHODS DETAILS
Mouse cell isolation and purification
Small intestine LP cells were isolated as previously described (Goodyear et al., 2014). Briefly, small intestine was opened longitudi-
nally and washed with HBSS (Thermo Fisher Scientific), cut and placed into HBSS 5 mM DTT (Sigma Aldrich). Next, tissues were
washed 3 times with HBSS 2% fetal bovine serum (FBS), 5 mM EDTA, minced into fine pieces and digested in HBSS supplemented
with 0.2 W€unsch units/mL Liberase TM (Sigma-Aldrich) and 200 Kunitz/mL DNase I (Biomatik). Cells were passed through a 70 mm
cell strainer (Falcon Products) and washed with RPMI complete medium supplemented with 20%FBS, 2mM L-glutamine, 100 U/mL
penicillin, 100 mg/mL streptomycin, 50 mM 2-mercaptoethanol.
In the indicated experiments, liver cell dissociation was performed as previously described (Allen et al., 2017). Briefly, liver was
perfused through the heart with 20 mL of PBS. The liver was extracted, minced into fine pieces and digested in HBSS containing
0.5 mg/mL of type IV Collagenase from Clostridium histolyticum (Sigma Aldrich) and 40 mg/mL DNase I (Biomatik) during 20 min
at room temperature. The digestion was stopped with FBS. The cells were filtered through a 70 mm cell strainer and centrifuged
at 54 x g 2 min at 4C. The supernatant was collected and centrifuged at the same speed twice. The final supernatant (non-paren-
chymal cells) was centrifuged at 300 x g 10 min at 4C and used for flow cytometry analysis.
Spleen and skin-draining lymph nodes or Peyer’s Patches (PPs) (5 per mouse/ 3 mice per sample) collected in RPMI complete
medium were mechanically dissociated using tweezers and a syringe plunger. Tissue homogenates were filtered through a 70 mm
cell strainer. In indicated experiments, PPs were digested as described (Bonnardel et al., 2015) using 100 mg/mL of type 2 collage-
nase from Clostridium histolyticum (Worthington Biochemical Corporation) and 140 mg/mL of DNase I (Biomatik) for 40 min at room
temperature andmyeloid cells were enriched by negative selection using a cocktail of biotin-conjugated antibodies (anti-CD3, CD19,
Biolegend) and Streptavidin-microbeads (Miltenyi Biotec).
Where further purification of naive CD4+ T cells from spleen and lymph nodes was required, cells were first enriched by negative
selection using a cocktail of biotin-conjugated antibodies (anti-CD11c, CD11b, B220, MHC-II, CD8, GR1, CD16/32, BD Bioscience)
and Streptavidin-microbeads (Miltenyi Biotec) and then sorted based on expression of CD44 and CD62L using a FACs Aria cell
sorter. Where indicated, cells were labeled with CellTracer Violet (5 mM, Thermo Fisher Scientific). Dome CD11b+, CD8a+ DCs,
LysoDCs and LysoMacs from PPs and CD3+ T cells or CD3- CD90.2+ ILCs from small intestine LP were purified using the FACs
Aria cell sorter.e5 Immunity 50, 446–461.e1–e9, February 19, 2019
Human intestinal samples
Human biopsies were collected in ice-chilled complete medium Dutch-modified RPMI-1640 containing 100 mg/mL penicillin/strep-
tomycin, 2 mM L-glutamine, 50 mg/mL gentamicine and 10% FBS (All reagents from Sigma-Aldrich) and processed immediately in
the laboratory by incubating them twice in HBSS containing 1 mM DTT and 1 mM EDTA for 30 min at 37C with 250 rpm rotation.
Intestinal biopsies were then digested in RPMI supplemented with 1 mg/mL of collagenase D (Sigma-Aldrich) for a maximum of
90 min at 37C with 250 rpm rotation. Intestinal LP cells were then passed through 100 mm cell strainers (Fisher) and washed in
FACS buffer (ice-cold PBS supplemented with 2.5 mM EDTA, 5% FBS, 0.2% sodium azide) before proceeding with the antibody
staining.
GM-CSF Bone Marrow-derived cells generation and stimulation
Cell suspensions from bone marrow of the indicated genotypes including WT, Myd88/ (Adachi et al., 1998), CD11cDSyk (Iborra
et al., 2012), Fcer1g/ (B6; 129P2-Fcer1gtm1Rav/J), Clec7a/ (Marakalala et al., 2013), Clec4n/ (Saijo et al., 2010) and
Clec4e/ (Wells et al., 2008) were cultured on tissue culture flasks (Falcon Products) in the presence of 20 ng/mL recombinant
GM-CSF (Miltenyi Biotec). GM-CSF BM-derived cells were collected on day 6, purified by positive selection with anti-CD11c-mi-
crobeads (Miltenyi Biotec) and plated 16 h before stimulation.
In the indicated experiments, GM-CSF BM-derived CD11c+ cells (GM-BM, 2x106/mL) were stimulated with LPS EB (100 ng/mL,
InvivoGen), plated TDB (1 mg/well, InvivoGen), zymosan (10 mg/mL, InvivoGen) or by co-culture with the indicated ratio of total micro-
biota from SPFmice, quantified by the optical density at 600 nm (OD600nm) together with quantification by flow cytometry, in the pres-
ence of 100 U/mL Penicillin and 100 mg/mL Streptomycin. Activation of GM-BMs was assessed by quantifying the upregulation of
MHCII, CD40, CD86, CCR7 or Syk phosphorylation.
For some experiments, GM-BMs were FACS-sorted based on the expression of MERTK and CD115 into conventional DCs
(GM-DCs) and monocyte-derived macrophages (GM-Macs) as previously described (Helft et al., 2015).
Cell stimulation and intracellular cytokine detection
For intracellular cytokine analysis, sorted T cells or ILCs from the small intestine LP were stimulated with PMA (Sigma Aldrich,
100 ng/mL) and ionomycin (Sigma Aldrich, 500 ng/mL) for 4 hours, in the presence of Brefeldin A in the last 3.5 hours (Sigma Aldrich,
5mg/mL). Cells were fixed with 4% paraformaldehyde (PFA) and incubated with anti-IL-17, anti-IL-22 or anti-IFN-g during permeabi-
lization with 0.1% saponin. For in vitro Th17 priming, splenic naive CD4+ cells were purified using MACS technology (Miltenyi Biotec)
according to manufacturers’ instructions. 104 CD4+ cells were incubated with plate-bound anti-CD3 (Clone 145-2C11, BioxCell,
1mg/mL) as well as soluble anti-CD28 (Clone 37.51, BioxCell, 2 mg/mL), anti-IFN-g (10 mg/mL), anti-IL-4 (10 mg/mL), TGF-b
(2 ng/mL), IL-6 (5 ng/mL) and IL-23 (20 ng/mL). All recombinant cytokines used in this assay were from Biolegend. IL-17A and
IL-22 production was assessed after 5 days by flow cytometry.
FACS-sorted DomeCD11b+, CD8a+ DCs, LysoDCs and LysoMacs fromPPs (53 103), GM-DCs andGM-Macs (53 104) orMACS-
purified GM-CSF BM-derived CD11c+ cells (1 x105) were co-cultured with FACS-sorted Celltrace Violet-labeled naive CD4+CD62L+
CD44- OT-II T (5x103 or 5 x104, respectively), and chicken ovalbumin peptide (OVA323-339, 100 mM) in 200 mL RPMI complete medium
in 96-well round-bottom plates. GM-CSF BM-derived CD11c+ cells, GM-DCs and GM-Macs were loaded previously with mucosa-
associated commensals at a 10:1 ratio, in the presence of 100 U/mL penicilin, 100 mg/mL streptomycin and 50 mg/mL gentamycin.
After 72h, cell proliferation was analyzed by Celltrace Violet dilution (flow cytometry) and supernatants assessed for IL-17 or IFN-g
quantification by ELISA. For re-stimulation, cells harvested after 72 h of primary culture were stimulated with PMA and ionomycin for
6 h (intracellular cytokine detection) in the presence of Brefeldin A in the last 4 hours of culture. Cells were stained for CD4, fixed with
4% PFA, and incubated with anti-IL-17, anti-IL-22 or anti-IFN-g during permeabilization with 0.1% saponin.
For intracellular IL-12p40 and IL-6 staining in vivo, mice were intraperitoneally inoculated with Brefeldin A (125 mg/mouse). PPs
were recovered 12 h after brefeldin A injection. The cells obtainedwere fixed and permeabilized andwere stained with PE conjugated
anti-IL-12p40 antibody (Tonbo) or APC anti-mouse IL-6 antibody or its isotype control antibody APC Rat IgG1, k (Biolegend).
Flow cytometry
Cells were pre-incubated for 10min at 4Cwith anti-mouse CD16/CD32 (clone 2.4G2, Tonbo Bioscience) or anti human Fc block (BD
Biosciences) to block unspecific antibody binding toward murine or human cells, respectively; before staining with the appropriate
antibodies. Samples for flow cytometry were stained in FACs buffer. Anti-mouse antibodies to CD45.1 (APC, PerCP-Cy5.5,
efluor450), CD45 efluor450, CD44 FITC, CD62L PE, CD8a PE, CD11b APC, biotin CCR7, IFN-g APC, CD172a (SIRPa)(biotin,
APC), Ly6C PerCP-Cy5.5, IgA PE and anti-human IgG (Fc gamma-specific) PE or biotin, were obtained from eBioscience.
Anti-mouse I-A/I-E (MHCII) FITC, CD44 V450, CD4 (APC, PerCP-Cy5.5), CD19 PE, CD11c (APC, PE), Siglec-F BV421, CD103
BUV395, CD11c BUV395, CD40 APC, IL17A (PE, APC-Cy7), CD45R/B220 BV421, CD11b FITC, Ly6G PE, and Streptavidin
BV786 were from BD Biosciences.
Anti-mouse F4/80 FITC, CD64 PECy7, I-A/I-E (MHCII) AF700, Ly6G BV510, CD11b BV605, CD172a (Sirpa) PerCPCy5.5, CD4
PECy7, CD45 BV510, CD90.2 (Thy-1.2) APC, CD196 (CCR6) PE, IL-17A BV605, IL-22 (PE, PerCP-Cy5.5), CD185 (CXCR5) (PE,
APC), CD279 (PD-1) (biotin, BV421), IgG1 PerCP-Cy5.5, CD11b APC-Cy7, MERTK (Mer) PE, CD317 (BST2, PDCA-1) APC,
CD197 (CCR7) PE and anti-human HLA-DR BV570, CD11c AF700, CD45 FITC were from Biolegend.Immunity 50, 446–461.e1–e9, February 19, 2019 e6
Anti-mouse CD86, CD4 PE, CD3 FITCwas from Tonbo Biosciences. Anti-mouse CD115 biotin was from ThermoFisher. Mouse and
humanMincle were stainedwith 1B6 anti-Mincle (MBL) biotinylated by using a biotinylation Kit (Abcam) or its isotype control antibody
biotin rat IgG1, k (Biolegend). Non-cell permeant Hoechst 33258 (0.1 mM, ThermoFisher) was used as a counterstain to detect murine
necrotic cells, while human dead cells were excluded from the analysis using a live/dead fixable near-infrared dead cell stain kit (Mo-
lecular Probes). Data was acquired on a LSR Fortessa (BD Biosciences) and analyzed with FlowJo software version 10 (TreeStar).
Microbiota and mucosa-associated commensals preparation and binding studies
For total microbiota analysis, fresh content from the whole intestine, except caecum, of SPF or germ-free mice was collected from
mice with ad libitum access to food and water. For mucosa-associated commensals isolation, SPF mice or mice treated with anti-
biotics in utero until the weaning and gavagedwith Lactobacillus plantarum (L. plantarum)were starved for 18 hours prior to collecting
the mucus by gentle scraping of the epithelium from the small intestine as previously described (Cohen and Laux, 1995). In both
cases, the samples were vortexed, filtered by 70 mm filter, centrifuged at 600 g 1 min to remove large particles, the supernatant
was centrifuged at 13000 g for 3 min and the pellet was diluted in to an OD600nm of 0.6 or count by flow cytometry by using Bacteria
Counting Kit (Thermo Fisher Scientific) as described (Veal et al., 2000). The analysis by flow cytometry was done as previously
described (Eriksson et al., 2013). Mincle-hFc, Dectin-1-hFc generated as described (Iborra et al., 2016), Dectin-2-hFc or Mincle-
hFc (R&D Systems) and control-hFc (R&D Systems) were prepared in 10% skimmed milk in PBS were incubated overnight at 4C
on a rotating wheel, washed three times and labeled with PE-conjugated goat anti-hFc antibody (eBioscience). SYTO 61 red fluores-
cent nucleic acid stain (ThermoFisher) at 2.5mMwas then incorporated and washed three time in PBS. For IgA-coated bacteria anal-
ysis, anti-mouse IgA PE (eBioscience) was added together with SYTO 61 red fluorescent nucleic acid stain.
For Mincle-hFc bound bacteria purification, anti-hFc stained bacteria were incubated with anti-PE microbeads (Miltenyi), washed
twice and then purified. After MACS separation, part of the negative and the positive fractions were collected for 16S sequencing
analysis.
Human Mincle-Fc chimera was blocked with anti-human Mincle 2F2 clone (Sigma-Aldrich); isotype matched antibody (clone
GC323, mouse IgM) was used as a control (Sigma Aldrich) or with Trehalose-6,6-dibehenate (TDB) (InvivoGen) prior microbiota stain-
ing assay.
CellTracer Violet Labeling of Lactobacillus plantarum
L. plantarum (ATCC14917) was grown overnight on MRS Broth medium (Oxoid) at 37C in aerobic conditions to approximately
OD600nm of 0.5. Bacteria were labeled with CellTracer Violet (100 mg/mL, Invitrogen). Bacteria were incubated 10 min at 30
C with
constant agitation, washed twice and inoculated by gavage in SPF WT mice starved for 18 hours and previously intraperitoneally
injected with 3 mg of cimetidine HCl (Sigma Aldrich) and 0.02 mg of sincalide (Tebu-bio). The mucosa-associated commensals
were collected 6 hours later for flow cytometry analysis.
RNA isolation and quantitative PCR
Total RNA from the liver parenchymal fraction, small intestine, ileum or PPs was isolated using Trizol (Thermo Fisher Scientific) in
combination with RNeasyMini Kit (QIAGEN) accordingly to manufacturer’s instructions. RNA was reverse transcribed to cDNA using
random hexamers and High Capacity cDNA Reverse Transcription Kit (Applied Byosystem). Quantitative PCR amplification was per-
formed with the GoTaq qPCR Master Mix (Promega) in a 7900HT Fast Real-Time PCR System (Applied Byosystem). All reactions
were done in triplicate, following the manufacturer’s instructions. Data were normalized to Gadph or bactin indicated in each case
and displayed as relative values. Primer sequences can be found in Table S1.
Immunofluorescence, confocal microscopy, and histology
For immunofluorescence of phospho-Syk (P-Syk), purified CD11c+ GM-BMs were adhered to coverslip and fixed with Fixation/Per-
meabilization Solution Kit (BD biosciences) after stimulation. Anti-P-Syk (C87C1) antibody from Cell Signaling was added and incu-
bated at 4C overnight. Samples were washed and anti-P-Syk was detected using the tyramide signal amplification (TSA) detection
kit Alexa Fluor 568 (Molecular Probes) as recommended by the manufacturer. For mucosa-associated commensals, mucus was
adhered to coverslips coatedwith poly-L lysine (50 mg/mL, Sigma Aldrich) overnight at 4C. Coverslips werewashed in PBS and fixed
in 2% PFA for 10 min at RT. Samples were then incubated with blocking solution (2% skimmed milk in PBS) for 60 min at room tem-
perature and stained with Mincle-hFc or Control-hFc followed by anti-human IgG (Fc gamma-specific) biotin (eBioscience) and
Streptavidin-Alexa 488 (ThermoFisher). Finally, samples were covered with ProLong Gold Antifade Reagent liquid mountant (Life
Technologies) and visualized using a Leica SP8 STED super resolution microscope. For Mincle expression analysis, PPs whole
mount preparations were done as described (Rios et al., 2016) and stained with anti-CD11c antibody (Clone 3.9, Abcam), biotin
anti-mouse Mincle (Clone 1B6, MBL), PE labeled anti-CD11b (Clone M1/70, BD biosciences), Alexa Fluor 647 Chicken Anti Mouse
IgG (H+L) (Molecular Probes), Alexa Fluor 488 Streptavidin (Thermo Fisher Scientific) and DAPI (Thermofisher). The samples were
fixed, covered as described and visualized using a Zeiss LSM 780 confocal microscope. Finally, anti-human Mincle antibody
(2A8, Abcam) was used for IHC on paraffin sections of healthy human colon samples as previously described (Iborra et al., 2016).e7 Immunity 50, 446–461.e1–e9, February 19, 2019
Enzyme-linked immunosorbent assays (ELISA)
IL-17 or IFN-g levels were determined using the mouse IL-17A (homodimer) ELISA Ready-SET-Go (Affymetrix) or the mouse IFN-g
ELISA Set (BD OptEIA) according to the manufacturer’s instructions. IL-23 and IL-6 were quantified using matched antibody pair
ELISA. Anti-mouse IL-23 p19 (5B2) together with biotinylated anti-mouse IL-12/IL-23 p40 (C17.8) both from Thermo Fisher Scientific.
Anti-Mouse IL-6 (MP5-20F3) (BD Biosciences) with biotinylated anti-mouse IL-6 (MP5-32C11) (Thermo Fisher Scientific). Flagellin or
LPS specific IgA were measured in the intestinal lavage as previously described (Cullender et al., 2013). Briefly, corning 96 well EIA/
RIA plates (Cultek) were coated overnight at 4C with 1 mg/mL of purified flagellin from Salmonella Typhimurium (InvivoGen) or 1 mg/
well of LPS EB (InvivoGen). Tomeasure total IgA, the plates were coated with goat anti-mouse IgA antibody (Bethyl) and the standard
curve done by using purified mouse IgA, k isotype control (BD PharMingen) as previously described (Bunker et al., 2015). To analyze
serum commensal bacteria-specific IgG, intestinal bacteria were prepared to coat ELISA plates, after heat-killing at 85C for 1 hour,
following a modified protocol from the previously described (Zeng et al., 2016). The plates were washed 3 times with PBS containing
0.05% Tween 20 and blocked with PBS containing 10% FBS for 1 hour at room temperature. Intestinal lavage was prepared by vor-
texing the intestinal content collected in 3 mL of PBS during 3 min. Samples were centrifuged at 8,000 g for 2 min and removed the
supernatant for assaying. Intestinal content supernatants or mice serum (to IgG analysis) were applied to the wells after the blocking
step and incubated at 4C o/n. The antibody used for detection was goat anti mouse IgA HRP (Southern Biotech) or goat anti mouse
IgG-heavy and light chain HRP (Bethyl) together with Sure Blue TMB 1-Component Microwell Peroxidase Substrate and TMB Stop
Solution (SeraCare). The absorbance was read at 450 nm.
Adoptive transfer experiments
Naive CD4+ T cells from B6/SJL mice expressing CD45.1 were negatively selected using a cocktail of biotin-conjugated antibodies
(anti-CD11c, CD11b, B220, MHC-II, CD8, GR1, CD16/32 (BD Bioscience) and anti-CD25, CD44 (Biolegend) followed by separation
with Streptavidin-microbeads (Miltenyi Biotec). 6x106 cells were adoptively transferred into recipient mice. IL-17 and IL-22 intracel-
lular production by flow cytometry in PPs T cells was determined 14 days after transfer by PMA and Ionomycin re-stimulation and
intracellular cytokine staining followed by flow cytometry.
Antibiotic Treatment, SFB quantification, and Lactobacillus plantarum colonization
For ablation of intestinal bacteria, an antibiotic cocktail of 1 g/L each of Ampicillin (Normon), Neomycin sulfate (Sigma Aldrich), Metro-
nidazole (Sanofi); of 0.5 g/L Vancomycin (Normon) and of 4mg/mL Sucralose (Sigma Aldrich) was used as previously described (Rak-
off-Nahoum et al., 2004). For selective depletion, Vancomycin alone was also used as previously described (Ivanov et al., 2008).
Antibiotics were added into the drinking water on aweekly basis. For treatment frombirth, breeding pairs were kept with the antibiotic
cocktail. Control cages were kept on regular water plus sucralose.
SFB in feces was detected by PCR (IDEXX Bioresearch). For SFB quantification in feces, microbial DNA was isolated from mouse
fecal samples using QIAamp PowerFecal Pro DNA kit (QIAGEN), according to manufacturer’s instructions. SFB DNA was then de-
tected by quantitative PCR with SFB specific primers (see Table S1) and SYBR-Green PCRmaster mix. SFB quantification was per-
formed with reference to a standard curve generated with quantified plasmid DNA where SFB 16S rRNA gene has been cloned in
PCR-blunt II vector (ThermoFisher) according to suppliers’ instructions.
Mice treated with antibiotics in utero until the weaning, were inoculated by gavagewith L. plantarum. One hour prior to the bacterial
gavage mice were injected intraperitoneally with 3 mg of cimetidine HCl (Sigma Aldrich) and 0.02 mg of sincalide (Tebu-bio) in 100 ml
of PBS to inhibit stomach acid secretion and empty the gallbladder to improve the colonization as previously described (Iida
et al., 2013).
For preparation of bacterial inocula, L. plantarum was grown overnight on MRS Broth medium (Oxoid) at 37C in aerobic condi-
tions. The bacteria were suspended in PBS. Mice were gavaged with 200 mL of inoculum (dose 1x106). Mice received doses every
two days during the four weeks.
FITC-Dextran permeability assay
Mice were orally gavaged with 4-kDa fluorescein isothiocyanate (FITC)–dextran probe (Sigma-Aldrich) (60 mg/100 g body weight).
Blood was collected 1 and 4 hours after and FITC-dextran measurements were performed in duplicate by fluorometry. Dilutions
of FITC-dextran in PBSwere used as a standard curve, and absorption of 100 mL of serum or standard wasmeasured in a fluorimeter
(Fluoroskan ascent, Thermo Scientific) at 488 nm.
Analysis of bacterial translocation
Liver was aseptically removed and homogenized in sterile-filtered 0.05% NP40 1% BSA PBS before plating serial dilutions on LB
agar plates, which were then incubated at 37C in aerobic conditions without light.
Bacterial DNA isolation and 16S gene sequencing
Ultra-Deep Microbiome Prep10 (Molzym) was used accordingly to manufacturer’s instructions to isolate enriched microbial DNA
from fresh liver and to remove of animal host DNA. Microbial genomic DNA from bound Control-hFc, Mincle-hFc or not bound
Mincle-hFc fractions or Mincle deficient mice and their WT littermates intestinal content was isolated by using QIAamp DNA Mini
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Sequencing Library Preparation guide (Illumina Inc.) The V3-V4 region of 16S rDNAwas amplified using the primers recommended in
this guide (see Table S1). One PCR reaction was performed per sample and one single amplicon of approximately 460 bp was
created. 2x Kapa HiFi Hot Start Ready Mix (Kapa Biosystems) was used for the first amplification step. AMPure XP beads (Beckman
Coulter) were used to purify the amplicons and to remove free primers and dimer species. Each amplicon (5 ml) were used as template
in a second Index PCR. This second PCR attached dual indices and Illumina sequencing adapters to each amplicon using the Nex-
tera XT index Kit (Illumina). An additional clean-up step was performed with the AMPure XP beads. All the libraries were run in a Bio-
analyzer DNA 1000 chip (Agilent Tecnologies) to verify the size of the product. Libraries were quantified by fluorometric method (Qubit
dsDNA) and quality was check in the 2100 Agilent Bioanalyzer. All libraries were diluted to the same concentration, using Illumina
Resuspension Buffer (RSB) and were combine an equal volume of all of them in the same pool to sequence. The sample pool
(10 nM) was denatured with 0.2 N NaOH, then diluted to 6 pM and combined with 50% (v/v) denatured 6 pM PhiX, prepared following
Illumina guidelines. Samples were sequenced on the MiSeq sequencing platform, using a 2 3 300 cycle V3 kit, following standard
Illumina sequencing protocols.
Processing of 16S sequencing data
Samples were analyzed using BaseSpace Application 16S Metagenomics v1.0 (Illumina) to determine the bacterial taxonomical
composition. This program use Illumina-curated version of the GreenGenes taxonomic database and RDP Classifier (Ribosomal
Database Project). For some additional data analysis, the ‘‘Quantitative Insights into Microbial Ecology’’ software (QIIME version
1.9.0) was used (Caporaso et al., 2010). Processed reads were then clustered in Operational taxonomic units (OTUs) using UCLUST
with a similarity threshold of 0.97 and were aligned using PyNast against 16S reference database GreenGenes version 13.8 using
default parameters. Enrichment index was obtained by comparing the relative abundance of each genus in Mincle-hFc-enriched
and depleted fractions. Specificity index was calculated by comparing the relative abundance of each genus in Mincle-hFc and
Control-hFc enriched fractions.
Serum hepatic parameters and metabolomics profiling
Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), total and indirect bilirubin were measured by using an automatic
biochemical analyzer (Dimension RxL Max Integrated Chemistry System, Siemens).
For metabolomics profiling, liver was collected after perfusion through the heart with cold PBS. An aliquot of approx. 20 mg was
immediately freeze-clamped in liquid nitrogen and stored at 80C until lipid extraction and analysis. Liver tissue was lysed in cold
MeOH:H2O (1:1, sample:solvent 1:10 ratio) with a TissueLyser LT homogenizer (QIAGEN). Afterward, liver homogenate was split in
two aliquots for themetabolomic profiling of diacylglycerides (DAG) and free fatty acids (FFA) using HPLC-ESI-MS-QTOF andGC-EI-
MS-QTOF (Agilent Technologies) as previously reported (Gonza´lez-Pen˜a et al., 2017). For DAG profiling, the resulting data matrix is
composed of all individual species of DAGs detected in the samples sorted by their characteristic retention time and neutral mass,
and the abundance of each compound for each sample. DAGs were identified by the exact mass and by the elucidation of MS/MS
spectra obtained using a LC-MS/MS analysis in production mode. In contrast, for FFA profiling, the resulting matrix is made of all
individual species of FFAs detected in the samples sorted by their characteristic retention time and target ion, and the abundance
of each compound for each sample. FFAs were identified by comparing their retention time, retention index and mass fragmentation
patterns with those available in an in-house library as described (Mastrangelo et al., 2015)
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis was performed using GraphPad Prism 5 (GraphPad Software). Statistical significance was determined by
parametric Student’s t test, by Mann & Whitney’s U test or one-way ANOVA with Bonferroni post hoc test unless otherwise stated.
Differences with p values% 0.05 were considered significant. *, p < 0.05; **, p < 0.01; ***, p < 0.001. n represents number of biological
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